文献速递中枢神经肿瘤放疗姑息放疗与转移瘤放疗物理与技术

海马及海马旁脑转移的发生率及其对海马保护放疗的影响:系统综述与Meta分析

Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: A systematic review and meta-analysis.
PubMed 文献 · Radiother Oncol · 2024-05-19

该系统综述与Meta分析纳入40项研究、共5374例患者和超过32570个脑转移灶,评估海马及海马旁脑转移的发生率及海马保护放疗后局部治疗不足的风险。结果显示海马转移发生率为4.4%(范围0-27%),海马旁转移为9.2%(3-41%),海马保护后海马区失败率为4.5%(0-13%),且海马保护未增加海马失败率(OR=1.90;p=0.17)。结论认为发生率较低,建议对未受累患者保护海马以保留神经认知功能和生活质量。

要点

  • 海马转移发生率4.4%(范围0-27%),海马旁转移9.2%(3-41%)。
  • 海马保护后海马区失败率4.5%(0-13%),多数可挽救性放射外科治疗。
  • 海马保护未增加海马失败率(OR=1.90;p=0.17)。

核心结论

  • 海马及海马旁脑转移总体发生率相当低,海马保护全脑放疗后局部治疗不足风险低。
  • 对未受累患者,应保护海马以保留神经认知功能和生活质量。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Embase和Scopus数据库。
  • 纳入报告海马和/或海马旁脑转移发生率或海马保护后失败率的研究。
  • 共纳入40项记录,涵盖5374例患者和超过32570个脑转移灶。

主要发现

  • 在报告脑转移发生率的研究中,4.4%(范围0-27%)的患者有海马转移,9.2%(范围3-41%)有海马旁转移。
  • 海马脑转移最常见的风险因素是脑转移总数。
  • 海马保护后海马区失败率为4.5%(范围0-13%),多数病例可通过放射外科挽救。
  • 小细胞肺癌组织学与海马失败风险升高无关(OR=2.49;p=0.23)。
  • 与常规全脑放疗相比,海马保护未增加海马失败率(OR=1.90;p=0.17)。

关键数值与推荐

  • 大多数研究采用5 mm边缘定义海马保护区。
  • 海马转移发生率4.4%(范围0-27%),海马旁转移9.2%(范围3-41%)。
  • 海马保护后海马区失败率4.5%(范围0-13%)。
  • 小细胞肺癌组织学与海马失败风险无关(OR=2.49;p=0.23)。
  • 海马保护与常规全脑放疗相比海马失败率无显著差异(OR=1.90;p=0.17)。

临床怎么用

  • 对未受累患者,应保护海马以保留神经认知功能和生活质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: In patients requiring prophylactic cranial irradiation (PCI) or whole-brain radiotherapy (WBRT) for brain metastases (BMs), hippocampal avoidance (HA) has been shown to preserve neurocognitive function and quality of life. Here, we aim to estimate the incidence of hippocampal and perihippocampal BMs and the subsequent risk of local undertreatment in patients undergoing hippocampal sparing radiotherapy. MATERIALS AND METHODS: MEDLINE, Embase, and Scopus were searched with the terms "Hippocampus", "Brain Neoplasms", and related terms. Trials reporting on the incidence of hippocampal and/or perihippocampal BMs or hippocampal failure rate after PCI or WBRT were included. RESULTS: Forty records were included, encompassing a total of 5,374 patients with over 32,570 BMs. Most trials employed a 5 mm margin to define the HA zone. In trials reporting on BM incidence, 4.4 % (range 0 - 27 %) and 9.2 % (3 - 41 %) of patients had hippocampal and perihippocampal BMs, respectively. The most common risk factor for hippocampal BMs was the total number of BMs. The reported failure rate within the HA zone after HA-PCI or HA-WBRT was 4.5 % (0 - 13 %), salvageable with radiosurgery in most cases. SCLC histology was not associated with a higher risk of hippocampal failure (OR = 2.49; p = 0.23). In trials comparing with a conventional (non-HA) PCI or WBRT group, HA did not increase the hippocampal failure rate (OR = 1.90; p = 0.17). CONCLUSION: The overall incidence of hippocampal and perihippocampal BMs is considerably low, with a subsequent low risk of local undertreatment following HA-PCI or HA-WBRT. In patients without involvement, the hippocampus should be spared to preserve neurocognitive function and quality of life.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Wiegreffe S, Sarria GR, Layer JP, et al. Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: A systematic review and meta-analysis. Radiother Oncol. 2024. PMID: 38772476. doi:10.1016/j.radonc.2024.110331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。